Searched for
CHLORTHALIDONE
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in the global an...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Long term Alpha generators: 8 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 27%After a long period of time, recently an Indian pharma company announced its intention to takeover a reasonably sized European company. Thi...
- Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- For all market conditions: 5 largecap stocks from different sectors with upside potential of up to 33%The US interest rates and yields are one of the most important drivers of liquidity in global markets. That is the reason at the first hint...
- For volatile markets: 5 largecap stocks from different sectors with upside potential of up to 31%In the last one month nifty and sensex have corrected. But the sentiment has not corrected as the broader market is still in the control of...
- Finally out of the woods? 4 small and midcap pharma stocks with an upside potential of up to 26%Pharma as a sector has been under pressure for a very long time. Some time USFDA issues, at other instances of pricing pressure in US marke...
- NPPA fixes retail prices of 23 drug formulationsSimilarly, the retail price of one tablet of Telmisartan, Chlorthalidone & Cilnidipine tablets at Rs 13.17. The retail price of one tablet ...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Sun Pharma, Aurobindo slide up to 2% as firms recall products in US marketAurobindo’s scrip fell to a low of Rs 612.60, 2 per cent lower than previous close on the National Stock Exchange, while Sun Pharma’s count...
- Aurobindo, Sun Pharma recall products in US marketAccording to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is r...
- Stocks in the news: RIL, Sun Pharma, ONGC, Natco Pharma and Tata MotorsReliance Powerreported 80 per cent decline in its consolidated net profit in June quarter.
- Unichem Laboratories gets USFDA nod for hypertension management drugThe approved product is a generic version of Hygroton tablets, 25 mg and 50 mg of Sanofi Aventis US, LLC.
- Zydus Cadila gets USFDA nod for blood pressure lowering drugZydus Cadila has received the final approval from the United States Food and Drug Administration to market Chlorthalidone tablets.
- Sun Pharma Q3 results today: Here's what experts sayEbitda margins to remain steady QoQ, at 22 per cent, Edelweiss said.
- Key diabetes, anti-cancer drugs among 92 in price-ceiling listThe National Pharmaceutical Pricing Authority said in orders dated August 13 that manufacturers of these drugs will fix their retail prices...
- NPPA fixes retail prices of 14 formulationsDrug price regulator has also asked manufacturers to furnish quarterly return regarding production, import and sale of their products.
Load More
